Get comprehensive analysis of Regeneron Pharmaceuticals, Inc. (REGN) stock with our professional-grade research platform. Our analysis combines DCF valuation models with AI-powered predictions to give you the complete picture.
Regeneron Pharmaceuticals, Inc. is a Healthcare company with a market capitalization of $94.91 billion. Currently trading at $917.49, the stock is up 1.45% today.
Regeneron Pharmaceuticals, Inc. (REGN) represents a significant investment opportunity in the Healthcare sector. Understanding the company's financial health, valuation metrics, and growth prospects is essential for making informed investment decisions.
Our analysis provides institutional-grade research typically reserved for professional investors, now available for free. We update REGN data daily to ensure you have the most current information for your investment decisions.